Impact of the COVID-19 Pandemic on the Collection and Analysis of Efficacy in Ongoing Clinical Trials

In this blog we will discuss key concepts related to the impact of COVID-19 specifically on programming. Impact on statistical inference will be considered in some parts of this article, but in-depth analysis of this is not within the scope of this article. This article is intended for trials which were ongoing during the COVID-19 pandemic, and not for trials specifically testing vaccines or treatments for COVID-19.

Impacts of the COVID-19 Pandemic on the Collection and Analysis of Disposition and Concomitant Medications

This blog considers the impacts of COVID-19 on the collection and analysis of disposition and concomitant medications, offering guidance from industry experts on what clinical data scientists [1] (i.e. those who analyse data collected in clinical trials) can expect in the short term relating to the studies impacted by the COVID-19 pandemic, as well as consideration of future implications.

From the Chair ... What You Can Expect from the PHUSE EU Connect 2020 Presentations

Even though PHUSE, our industry, and individuals were facing immense uncertainty at the height of the COVID outbreak, 232 abstracts were submitted to the EU Connect 2020 call for papers tool! Read more to find out what you can expect from the EU Connect presentations this year.


The celebratory success of our Single Day Events so far speaks for itself. Spring House, Pune, Frenchtown and Bengaluru have all hosted more than quadruple their physical capacity. The virtualisation welcomed an amazing 1,700+ attendees, in comparison to the 400-person capped physical capacity.

Impact of the COVID-19 Pandemic and Collection/Analysis of Laboratory Data in Ongoing Clinical Trials

Since late 2019/early 2020, the global COVID-19 pandemic has impacted all aspects of daily life. Ongoing clinical trials have been impacted in multiple ways, including but not limited to delays in screening and enrolment of subjects into trials, challenges with maintaining the trial schedule for ongoing subjects due to temporary site closures, lack of continuous drug supply, and subjects experiencing new and unexpected adverse events. The safety of clinical trial participants must be ensured despite these challenges.

First Prev Page 1 of 34 Next Last

Thinking of joining PHUSE?

Already a member but not sure how you can benefit?

PHUSE is an expanding, global society with a global membership of clinical data scientists. It requires a large pool of resources to help with its running, and so there are many opportunities for members to become involved. Whether it's chairing a conference, presenting at an event, leading a working group or contributing to the quarterly online newsletter, we are always keen to hear from volunteers.

Find Out More